BICHEN PHARMACEUTICAL
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.
BICHEN PHARMACEUTICAL
Social Links:
Industry:
Biopharma Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.abmtx.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Amazon Apache Microsoft Exchange Online Office 365 Mail GoDaddy DNS Japanese Yen
Similar Organizations
Allorion Therapeutics
Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.
Jisi Yingda
Jisi Yingda is a small-molecule anti-cancer drug developer, in the field of small-molecule tumor immune drugs and tumor drug development.
Marius Pharmaceuticals
Marius Pharmaceuticals is a biopharmaceutical company that brings novel treatments to a range of diseases with unmet medical needs.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Tarsier Pharma
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.
Investors List
Delta Capital
Delta Capital investment in Series B - Bichen Pharmaceutical
Sincere Capital
Sincere Capital investment in Series B - Bichen Pharmaceutical
Viva BioInnovator
Viva BioInnovator investment in Series B - Bichen Pharmaceutical
Highlight Capital
Highlight Capital investment in Series B - Bichen Pharmaceutical
Photon Fund
Photon Fund investment in Series B - Bichen Pharmaceutical
Baidu Ventures
Baidu Ventures investment in Series B - Bichen Pharmaceutical
Kaitai Capital
Kaitai Capital investment in Series B - Bichen Pharmaceutical
Tongde Capital
Tongde Capital investment in Series B - Bichen Pharmaceutical
Honghui Capital
Honghui Capital investment in Series B - Bichen Pharmaceutical
Sinopharm Capital
Sinopharm Capital investment in Series A - Bichen Pharmaceutical
Official Site Inspections
http://www.abmtx.com
- Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
- IP address: 3.33.152.147
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Bichen Pharmaceutical"
ABM-About Us - abmtx.com
Contact Us Email: [email protected] Company Overview ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as …See details»
Abmtx 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Abmtx. Use the PitchBook Platform to explore the full profile.See details»
ABMTX - Products, Competitors, Financials, Employees, …
About ABMTX ABM Therapeutics is a drug discovery company focused on small molecule targeted therapies within the biopharmaceutical industry. The company develops treatments …See details»
ABM Therapeutics - Company Profile & Staff Directory | ContactOut
ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain …See details»
ABM Therapeutics - Viva BioInnovator
ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain …See details»
CRC Oncology – Caring | Sharing | Supporting
Dec 10, 2019 For more information, please contact [email protected]. About CRC Oncology CRC Oncology is a contract research organization (CRO) focused on reshaping the global …See details»
Bichen Pharmaceutical - Crunchbase Company Profile & Funding
Bichen Pharmaceutical is a small-molecule tumor-targeted drug developer for the treatment of various malignant tumors and brain metastases.See details»
abmtx.com - ABM-Home
Apr 12, 2024 ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast …See details»
ABM Therapeutics Overview | SignalHire Company Profile
ABM is an innovative drug discovery and development company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain …See details»
ABM Therapeutics Receives IND Approval in China for …
Nov 30, 2021 ABM-1310 is a brain-penetrant BRAF inhibitor. Due to its high selectivity and optimal physicochemical properties, as well as superior efficacies and high margin of safety in preclinical models, it ...See details»
ABM Therapeutics Company Overview, Contact Details
Jan 4, 2022 Learn more about ABM Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
ABM-Investors - abmtx.com
KAITAI CAPITAL, founded in 2009, is a professional investment management organization that mainly engaged in innovative investment, industrial investment, and wealth management …See details»
ABM-R&D Strategy - abmtx.com
ABM-1310 is highly potent and selective BRAF inhibitor with an excellent cell permeability and brain penetration. The compound was designed to address majority of BRAF V600E mutated …See details»
ABM-About Us - abmtx.com
Contact Us Email: [email protected] Management Team Chen Chen, Ph.D. Chairman & CEO, Founder Dr. Chen is founder and CEO of ABM. Before ABM was established, Dr. Chen was …See details»
ABM-News - abmtx.com
Founded in 1907, the American Association for Cancer Research (AACR) is the first and largest cancer research organization dedicated to accelerating the conquest of cancer. It has over …See details»
ABM-About Us - abmtx.com
Contact Us Email: [email protected] Mission We are committed for scientific excellence and innovation. We are passionate about taking challenges and tirelessly pursuing best medical …See details»
American Beacon Mid-Cap Value F (ABMTX) - Yahoo Finance
See the company profile for American Beacon Mid-Cap Value F (ABMTX) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
璧辰医药-ABM Therapeutics, Inc-企业详情-InvestGO数据库 …
Dec 31, 2014 查看医药魔方InvestGO®数据库璧辰医药的公司信息。璧辰医药（ABM Therapeutics, Inc），公司简介：ABM is an innovative drug discovery and development …See details»
ABM Therapeutics Announces First Patient Dosed in Phase 1 …
SAN DIEGO, June 22, 2020 /PRNewswire/ -- ABM Therapeutics, a clinical-stage biopharmaceutical company developing a new generation of BRAF inhibitor, today announced …See details»
American Beacon Mid-Cap Value F (ABMTX) - Yahoo Finance Canada
Apr 30, 2025 Find the latest American Beacon Mid-Cap Value F (ABMTX) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»